½ÃÀ庸°í¼­
»óǰÄÚµå
1513570

Åõ¼®±â ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ¼¼°è ¿¹Ãø(2024-2032³â)

Dialysis Machines Market - By Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines), By End-use (In-center Dialysis, Home center dialysis) Global Forecast (2024 - 2032)

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 89 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Åõ¼®±â ±â¼ú Çõ½ÅÀ¸·Î Åõ¼®±âÀÇ È¿À²¼º°ú ȯÀÚ ÆíÀǼºÀÌ Çâ»óµÇ°í ¼¼°è °¢±¹ Á¤ºÎÀÇ Àû±ØÀûÀÎ ³ë·ÂÀ¸·Î Åõ¼®±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2032³â±îÁö CAGR 4.3%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÈÞ´ë¿ë ¹× ÀçÅà ġ·á¿Í °°Àº ±â¼ú Çõ½ÅÀº Æí¸®ÇÑ ½ÅÀå Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á °³Çõ°ú ÀçÁ¤ Áö¿øÀ» ÅëÇÑ Á¤ºÎ Áö¿øÀº Á¢±Ù¼º°ú °æÁ¦¼ºÀ» ´õ¿í Çâ»ó½ÃÄÑ ½ÃÀåÀÇ Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇյǾî Åõ¼®±â »ê¾÷Àº Àü ¼¼°èÀûÀ¸·Î ¸¸¼º ½ÅÀå ÁúȯÀÇ È®»ê¿¡ ´ëÀÀÇϱâ À§ÇØ Á¡Á¡ ´õ °ß°íÇØÁö°í ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 9¿ù KUTRRH´Â ÄÉ³Ä Á¤ºÎ°¡ ±¸ÀÔÇÑ Åõ¼®±â 20´ë¸¦ µµÀÔÇß½À´Ï´Ù. ÀÌ Àåºñ´Â ½ÅÀå ÀǷḦ Çõ½ÅÀûÀ¸·Î º¯È­½ÃÄÑ ¸¹Àº ȯÀÚµéÀÌ ½ÅÀå ¹®Á¦¿¡µµ ºÒ±¸ÇÏ°í »îÀÇ ÁúÀ» À¯ÁöÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±ÇÏ°í ½ÅÀå Áúȯ ȯÀÚÀÇ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇÑ ³ë·ÂÀÇ Áõ°¡¸¦ ½Ã»çÇÕ´Ï´Ù. ¶ÇÇÑ ½ÅÀå ÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀÇ Ä¡·á Á¢±Ù¼º°ú »îÀÇ ÁúÀ» °³¼±Çϱâ À§ÇÑ À¯»çÇÑ ³ë·ÂÀ¸·Î ÀÎÇØ Åõ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÒ °¡´É¼ºÀ» ¹Ý¿µÇÕ´Ï´Ù.

Åõ¼®±â ½ÃÀåÀº Á¦Ç° À¯Çü, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

º¹¸· Åõ¼®±â ºÐ¾ß´Â Á¢±Ù¼º, ºñ¿ë È¿À²¼º, ÀçÅà ġ·á¿¡ ´ëÇÑ È¯ÀÚ ¼±È£µµ µîÀÇ ÀåÁ¡¿¡ ÈûÀÔ¾î 2032³â±îÁö ÁÖ¸ñÇÒ ¸¸ÇÑ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü¹® ½Ã¼³ÀÌ ÇÊ¿äÇÑ Ç÷¾× Åõ¼®°ú ´Þ¸® º¹¸· Åõ¼®Àº Áý¿¡¼­ ÇÒ ¼ö ÀÖ¾î Æí¸®Çϰí ÀÇ·áºñ ÁöÃâÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. º¹¸·Åõ¼®±â´Â Áö¼ÓÀûÀÎ Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϸç, ÀæÀº º´¿ø ¹æ¹® ¾øÀ̵µ Á¤±âÀûÀ¸·Î ü³» µ¶¼Ò¸¦ Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ÀçÅà ÀÇ·á ¿É¼Ç È®´ë¿¡ ÃÊÁ¡À» ¸ÂÃ߸鼭 º¹¸· Åõ¼®±â µµÀÔÀÌ Áõ°¡ÇÏ°í ½ÃÀåµµ ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù.

ÀçÅà Åõ¼® ºÐ¾ß´Â ȯÀÚ Áß½ÉÀÇ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ 2032³â±îÁö Å« ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀçÅà Åõ¼®ÀÌ ´õ¿í Ä£¼÷Çϰí È¿À²ÀûÀÌ µÇ¾î ȯÀÚµéÀÌ Æí¸®ÇÏ°Ô Ä¡·á¸¦ °ü¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÇ·á ºñ¿ë Àý°¨, Ä¡·á °á°ú °³¼±, ȯÀÚÀÇ ÀÚÀ²¼º Çâ»ó µîÀÇ ¿äÀÎÀÌ ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ¸¸¼ºÄáÆÏº´ ȯÀÚµéÀÌ Áý¿¡¼­ Æí¾ÈÇÏ°Ô Ä¡·á¹ÞÀ¸¸é¼­ »îÀÇ ÁúÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï °³ÀÎÈ­µÈ ÀÇ·á ¼Ö·ç¼ÇÀ¸·ÎÀÇ ÀüȯÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Åõ¼®±â »ê¾÷ Á¡À¯À²Àº 2032³â±îÁö »ó´çÇÑ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÇ·á ÁöÃâ Áõ°¡, ½ÅÀå ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¿¡ ±âÀÎÇÕ´Ï´Ù. Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡¿¡¼­´Â ÷´Ü ÀÇ·á ±â¼úÀÇ ±Þ¼ÓÇÑ µµÀÔÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÀå Áúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ³óÃÌ Áö¿ªÀÇ ÀÇ·á Á¢±Ù¼ºÀÌ °³¼±µÇ¸é¼­ ÀÌ Áö¿ªÀÌ ¼¼°è Åõ¼®±â ½ÃÀå¿¡¼­ Áß¿äÇÑ ±â¿© ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸»±â ½ÅÀåÁúȯ(ESRD) ȯÀÚ Áõ°¡
      • ´ç´¢º´ Áõ°¡
      • °ø¿©ÀÚ ½ÅÀåÀÇ ºÎÁ·
      • Åõ¼® Ä¡·á¿¡ À¯¸®ÇÑ »óȯ ½Ã³ª¸®¿À
      • ¼±Áø±¹ ¹× °³¹ßµµ»ó±¹ÀÇ ¿¬±¸°³¹ß ÅõÀÚ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • Á¦Ç° ¸®ÄÝ
      • Ä¡·áÀÇ ÇÕº´Áõ
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ÀçÅà Åõ¼® Àü¸Á
  • ±ÔÁ¦ »óȲ
  • »óȯ ½Ã³ª¸®¿À
  • ¹ë·ùüÀÎ ºÐ¼®
  • ±â¼úÀû Àü¸Á
  • Porters ºÐ¼®
  • PESTEL ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå °æÀï »óȲ

  • ¼Ò°³
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : Á¦Ç° À¯Çüº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Ç÷¾× Åõ¼® ±â±â
  • º¹¸· Åõ¼® ±â±â

Á¦6Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ¼¾Åͳ» Åõ¼®
  • ÀçÅà Åõ¼®

Á¦7Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : Áö¿ªº°, 2021-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ±â¾÷ °³¿ä

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Dialife SA
  • Fresenius SE & Co. KGaA
  • JMS Co., Ltd.
  • Medtronic plc
  • Nikkiso Co Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Inc.
  • Toray Medical Co., Ltd.
ksm 24.07.19

Global Dialysis Machines Market size will accumulate a 4.3% CAGR from 2024 to 2032, owing to technological breakthroughs in dialysis machines, enhancing efficiency and patient comfort, in line with proactive government initiatives globally. Innovations such as portable and home-based solutions cater to rising patient demand for convenient renal care options. Government support through healthcare reforms and funding further boosts accessibility and affordability, expanding the market reach. These factors collectively pave the way for an increasingly robust dialysis machines industry, addressing the growing prevalence of chronic kidney diseases worldwide.

For instance, in September 2023, KUTRRH introduced 20 dialysis machines purchased by the Kenyan government, crucial in replicating kidney functions. These devices have transformed renal care, allowing many patients to maintain quality of life despite kidney challenges. This development suggests a growing commitment to improving healthcare infrastructure and addressing the needs of patients with kidney diseases. It also reflects a potential increase in demand for dialysis machines globally, driven by similar initiatives aimed at enhancing treatment accessibility and quality of life for patients suffering from renal conditions.

The dialysis machines market is classified based on product type, end-use, and region.

The peritoneal dialysis machines segment will garner noteworthy market share by 2032, propelled by its advantages in accessibility, cost-effectiveness, and patient preference for home-based treatments. Unlike hemodialysis, which requires specialized centers, peritoneal dialysis can be performed at home, offering greater convenience and reducing healthcare expenditures. These machines facilitate continuous treatment, ensuring regular toxin removal from the body without the need for frequent hospital visits. As healthcare systems focus on expanding home healthcare options, peritoneal dialysis machines will see increased adoption and market growth.

The home dialysis segment will establish a substantial foothold by 2032 due to rising demand for patient-centric care options. Advancements in technology have made home dialysis more accessible and efficient, allowing patients to manage treatments conveniently. Factors such as reduced healthcare costs, improved treatment outcomes, and greater patient autonomy contribute to the segment's growth. This trend underscores a shift towards personalized healthcare solutions, empowering patients with chronic kidney diseases to maintain their quality of life while managing their condition from the comfort of home.

Asia Pacific dialysis machines industry share will register a notable CAGR through 2032, attributed to increasing healthcare expenditure, the growing prevalence of renal disorders, and expanding access to healthcare facilities. Countries like China and India are witnessing rapid adoption of advanced medical technologies, while government initiatives to improve healthcare infrastructure further drive market growth. Additionally, rising awareness about kidney diseases and improving healthcare access in rural areas contribute to the region's prominence as a significant contributor to the global dialysis machines market.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
      • 3.2.1.2 Increasing incidence of diabetes
      • 3.2.1.3 Shortage of donor kidneys
      • 3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
      • 3.2.1.5 R&D investments in developed as well as developing countries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Product recalls
      • 3.2.2.2 Complication in the treatment
  • 3.3 Growth potential analysis
  • 3.4 Home dialysis landscape
  • 3.5 Dialysis market, 2021 -2032
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Value chain analysis
  • 3.9 Technological landscape
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis machines
  • 5.3 Peritoneal dialysis machines

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 In-center dialysis
  • 6.3 Home center dialysis

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 B. Braun Melsungen AG
  • 8.2 Baxter International Inc.
  • 8.3 Dialife SA
  • 8.4 Fresenius SE & Co. KGaA
  • 8.5 JMS Co., Ltd.
  • 8.6 Medtronic plc
  • 8.7 Nikkiso Co Ltd.
  • 8.8 Nipro Corporation
  • 8.9 Outset Medical, Inc.
  • 8.10 Quanta Dialysis Technologies Inc.
  • 8.11 Toray Medical Co., Ltd.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦